Back to top

Clinical trial to test GDNF in Parkinson's

Clinical trial to test GDNF in Parkinson's

Can Parkinson's be slowed with GDNF treatment video

We're supporting a groundbreaking clinical trial of an experimental treatment for Parkinson's.

Neurologist Alan Whone and his team have tested whether GDNF can slow down Parkinson's.

Watch the video and see below to learn more.

About GDNF

What is GDNF?

Drawing of brain cells

Find out more about this groundbreaking study, how the trial took place, and how we hope it will work.

GDNF trial - results on the way

Brain scans

The groundbreaking clinical trial of GDNF is now complete. Analysis of the results is now underway and is expected to be published in summer 2017.

Time for a new treatment

Donate to help continue our research

We need your help - donate today and help make more research into Parkinson's happen.

What next?

Questions about GDNF?

See frequently asked questions

Read our FAQs about GDNF

 

Get regular research updates

Join our Research Support Network

More on GDNF

Meet the team behind the GDNF trial

In this blog, we chat to the people who made the trial happen, including researchers, participants and drug companies.

My life in research by Chris Proctor

Chris, one of the 41 participants in the GDNF trial, shares what inspired her to get involved in Parkinson’s research.

Donate today

Help make more research like GDNF happen, so we can find better treatments and a cure for Parkinson's.